In November 2016, Jia Yueting, the founder of LeTV, posted a thank you on Weibo for the investment in Super Car, mentioning Liu Shaoxi of Yihua Group. At that time, the two were prosperous, Jia Yueting received many investments, and Liu Shaoxi's career was "booming."

On November 15, 2016, leaders of more than a dozen well-known domestic enterprises, including Heilan Group, Hengxing Group, Yihua Group, Minhua Holdings , Yuyue Group, Luye Group, etc., gathered at LeTV Building to formally cooperate with LeTV Holdings signed an investment agreement for the first phase of US$300 million.

Due to his participation in the operations of many listed companies, Liu Shaoxi is a household name in the local area and is known as the "Godfather of Chaoshan Capital". There is a popular saying in Shantou Chenghai local area, "Chenghai San Mo Shi (dialect, means not able to die), Xue Min, must be filial, Liu Shaoxi."

He has many firsts. On August 24, 2004, Yihua Wood Industry was listed on the Shanghai Stock Exchange, becoming the first private enterprise in Shantou to be successfully listed. Later, Yihua Real Estate went public through S*ST Optoelectronics, becoming the first listed company in the real estate industry in eastern Guangdong, and later changed its name to Yihua Health. 2019 years ago, Liu Shaoxi ranked 3rd on the Hurun Rich List with a net worth of 7500 million yuan.

Times have changed, and Jia Yueting has become the "No. 1 Lao Lao" in the 21st century due to a broken capital chain. In 2020, Yihua Life and Yihua Health, two subsidiaries owned by Liu Shaoxi, experienced "thunders" one after another.

html On April 26, Yihua Life announced that it had been investigated by the China Securities Regulatory Commission due to suspicion of illegal disclosure of information. Yihua Life stated that the company's stocks may be at risk of being forced to delist due to major violations of the law.

Yihua Life’s net profit attributable to shareholders of the parent company in 2019 was a loss of 185 million yuan, a year-on-year decrease of 147.92%. At the end of 2019, monetary funds were only 405 million yuan, a significant decrease of 88.06% compared with the same period in previous years; the balance of prepayments was 2.319 billion yuan, a significant increase of 271.26% from the beginning of the period; the balance of short-term borrowings was 3.716 billion yuan, and non-current liabilities due within one year were 2.474 billion yuan. , totaling 6.191 billion yuan.

Yihua Life’s 2019 annual report was issued an audit report with a disclaimer of opinion by Asia Pacific (Group) Accounting Firm. On April 29, the Shanghai Stock Exchange also sent a letter of inquiry to Yihua Life regarding its poor financial situation.

Not only that, Yihua Health also suffered a huge loss of 1.8 billion yuan in 2019. Before Yihua Life was put under investigation, the rating agency China Chengxin International downgraded the main body and two debt ratings of Yihua Group.

China Chengxin International believes that as of April 24, Yihua Group’s existing bonds in the open market exceeded 5 billion yuan, and there will be great pressure to repay the bonds due in 2020.

Data map: Mao Amin participated in the program "Flowers and Boys".

"Mao Amin's husband" and the boss of the Zhongzhi department Xie Zhikun are in trouble

Recently, there are media reports that the Beijing Securities Regulatory Bureau will join forces with the Jiangsu Securities Regulatory Bureau to investigate the four major wealth companies of the Zhongzhi department Hengtian Fortune and Xinhu Fortune , Datang Wealth, and Gaosheng Wealth conducted on-site inspections to understand the true scale and risk profile of the four major wealth management companies.

However, Zhongzhi Group issued a statement on the 12th saying that recently, a number of self-media and public accounts have published false information about the company, transforming the general inspections of the company by regulatory agencies into special investigations of the company. The company's reputation is greatly negatively affected. The company and its affiliated enterprises operate in accordance with laws and regulations, and all business work is carried out in a normal and orderly manner.

It was previously reported that the regulatory authorities had asked Zhongzhi to merge the four major wealth companies to reduce the room for maneuver. However, due to the different equity structures of each company, Zhongzhi has been unable to proceed.

Although on the 2017 Forbes China Rich List, Xie Zhikun ranked 116th with a net worth of 14 billion yuan. However, due to his low-key approach, Xie Zhikun, the helmsman of the "Zhongzhi Department", is mainly known to the outside world as "Mao Amin's husband" and "Xie Zhichun's younger brother".

Mao Amin and Xie Zhikun have two sons. Xie Zhichun was the president of Everbright Securities Co., Ltd., the vice president of China Everbright Bank, the deputy general manager of China Everbright (Group) Corporation and the chairman of Sun Life Everbright Life Insurance Co., Ltd. In 2014, he served as the deputy general manager and of China Investment Corporation. General Manager of of Central Huijin Company.

Because of this relationship, whether the "Zhongzhi Series" and "Ebright Series" are blended has always caused market controversy. However, in May 2015, Xie Zhichun no longer served as the deputy general manager of China Investment Corporation and announced that he had returned to his true life. The label of brother Xie Zhikun gradually faded away.

In recent years, Jie Zhikun, who has a "trillion-level" asset empire, has had a lot of troubles.

Under the "heavy blow" in the financial industry, Anbang was taken over, HNA was "short of money", Tomorrow System plans to sell 500 billion yuan in assets, and Zhongzhi Group is not immune.

In 2002, Zhongzhi Group and others invested in the reorganization of Zhongrong Trust. After more than ten years of development, Zhongrong Trust ranks first in the trust industry alongside CITIC Trust and Ping An Trust . In 2017, Zhongrong Trust ranked second in the industry in revenue and fourth in profit.

However, on March 12, Jingwei Textile Machinery announced that it would acquire the 32.98% equity of Zhongrong Trust held by Zhongzhi Group through a combination of shares and cash, which also means that Zhongzhi Group has lost the actual control of Zhongrong Trust. .

If you sort out the ownership structure of Zhongzhi Group, Zhongrong Trust is the capital operation hub of Zhongzhi Group. Even if it controls 10 listed companies and holds shares in more than 20 listed companies, losing Zhongrong Trust will still cause huge losses to Zhongzhi Group. Therefore, Zhongrong Trust was taken over by a central enterprise, which was interpreted by the outside world as Zhongzhi "abandoning the car to save the handsome man".

"The King of Traditional Chinese Medicine" Ma Xingtian The couple's financial fraud scandal has not been resolved

Recently, the "financial fraud professional" Kangmei Pharmaceutical has been targeted by the China Securities Regulatory Commission.

"The road is to the end of the world, two hearts are dependent on each other, the wind can't blow away the oath, the rain can't wet the romance, the intention is to relieve the suffering and pain of the people, the love is the happiness and joy of the world..." Many people are because of the previous "Kangmei" "Love" advertisement is familiar to Kangmei Pharmaceutical. It is said that the male and female protagonists of the MV at that time performed the love story of Kangmei Pharmaceutical founder Ma Xingtian and Xu Dongjin.

The picture shows a screenshot of the advertisement for "Kangmei Love".

However, in reality, Kangmei Pharmaceutical may not have achieved the goal of "relieving the suffering and pain of the people, and bringing joy and joy to the world", at least not to investors.

html On the evening of May 10, Kangmei Pharmaceutical announced that the company and its executives had recently received a warning letter from the Guangdong Supervision Bureau of the China Securities Regulatory Commission. The China Securities Regulatory Commission believes that ST Kangmei's net profit attributable to the parent company in 2019 was revised from -1.35 billion yuan to -1.65 billion yuan to -3.648 billion yuan. The net profit changed significantly after the revision. The previously disclosed information related to the performance forecast was inaccurate. The company failed to disclose the performance forecast revision announcement in a timely manner, and there were information disclosure violations.

This is another problem with Kangmei Pharmaceutical’s annual report disclosure after the 2017 annual report, 2018 annual report, and 2018 semi-annual report were “qualitatively” financially fraudulent.

In April 2019, while disclosing the 2018 annual report, Kangmei Pharmaceutical restated its 2017 financial statements, saying that due to errors in calculating account funds, monetary funds were overstated by 29.944 billion yuan. The amount is so large that it is surprising Jaw-dropping. After

, after investigation by the China Securities Regulatory Commission, more "truths" emerged. In the past three years, Kangmei Pharmaceutical has inflated revenue by nearly 30 billion yuan, operating profit by 3.936 billion yuan, and monetary funds by 88.7 billion yuan. In addition, there are suspicions of stock price manipulation.

What is disappointing is that Kangmei Pharmaceutical was once a famous "white horse stock", setting a historical record with a market value of 139 billion yuan. In the past, it was said that "Kangmei Pharmaceutical's tax payment accounts for one-third of the tax revenue of Puning City and one-sixth of the tax revenue of Jieyang City."

On the Hurun Rich List, in 2016, the Ma Xingtian family ranked 46th with a wealth of 33 billion yuan; in 2018, the Ma Xingtian family ranked 52nd with a wealth of 41 billion yuan; after the fraud scandal was exposed in 2019, the Ma Xingtian family directly Dropped to No. 723.

Kangmei Pharmaceutical's stock was also subject to a risk warning. The stock abbreviation was changed from "Kangmei Pharmaceutical" to "ST Kangmei". The market value fell off a cliff, triggering many shareholders to defend their rights, far more than Kangdexin, which was also involved in financial fraud. Some media pointed out that Kangmei Pharmaceutical's claims may become the largest number of claimants and the largest amount of claims in the history of A-shares.

According to the maximum punishment imposed by the China Securities Regulatory Commission on Kangmei Pharmaceuticals, Ma Xingtian and Xu Dongjin were banned from the securities market for life. However, compared to Kangde Xinyuan’s actual controller Zhong Yu, who was imprisoned for suspected misappropriation of funds and other crimes, Ma Xingtian and his wife The results are much better.

After the financial fraud incident, the crisis of Kangmei Pharmaceutical has not been resolved.The third quarter report of 2019 shows that Kangmei Pharmaceutical has only 480 million yuan in cash on its books, but its accounts receivable and other receivables total more than 14 billion yuan.

At the end of 2019, Kangmei Pharmaceutical received a "life-saving straw" - a syndicated loan of about 10 billion yuan. Among them, the loan interest rate is 4.275%, which is much lower than Kangmei Pharmaceutical’s previous bank loans. Unexpectedly, there is now another "big hole" in Kangmei Pharmaceutical's annual report.

Some netizens lamented: During the growth process of private enterprises, they have enjoyed a lot of sunshine and experienced a lot of darkness. Perhaps with an opportunity, the dirty information will become known to the world. (End)